FTO and obesity due to melanocortin 4 receptor deficiency: In PCOS, FTO variation seems to be a key marker for IR, either directly i.e. to some degree independent of BMI/obesity or secondary due to its impact on body weight which in turn has an impact on glucose intolerance and diabetes.